Many
classification systems have come and gone over the years. Here is a
brief history of them.
Rappaport and Lukes Collins
This classification was developed before lymphoid cells were divided
into B-cells and T-cells. It was developed in 1966 with the Lukes
Collins modifications in 1974
Working Formulation
This was developed by the National Cancer Institute in 1982 as a
method of translating among the recognized classification systems
for non-Hodgkin lymphoma (Rappaport, Dorfman, Lukes and Collins,
Kiel, and the British Lymphoma system). The major groups are
identified by letters, A - J, and grouped according to prognosis:
most favorable
Low Grade
A, B, C
Intermediate Grade
D, E, F, G
least favorable
High Grade
H, I, J
Low Grade
Intermediate Grade
High Grade
Small lymphocytic
Follicular large
cell
Large cell
immunoblastic
Follicular
small-cleaved cell
Diffuse small
cleaved cell
Lymphoblastic
Follicular mixed
small-cleaved and large cell
Diffuse mixed
small and large cell
Small non-cleaved
cell (Burkitt and non-Burkitt type)
Diffuse large cell
Cell types
categorized as unclassified by the Working Formulation include the
non-specific terms malignant lymphoma, non-Hodgkin lymphoma, diffuse
malignant lymphoma, nodular or follicular malignant lymphoma, and
cutaneous lymphoma.
Differences in
histology refer to differences in the first 3 digits of the ICD-O
morphology code.
A simultaneous
diagnosis of malignant lymphocytic lymphoma (small cell type) and
chronic lymphocytic leukemia (CLL) is coded to CLL